United States · FDA National Drug Code directory
LEVOXYL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60793-854_e230c170-2a16-47d0-bce7-ac0414c192f7
- Product NDC
- 60793-854
- Form
- TABLET
- Composition / generic term
- levothyroxine sodium
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20010525
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 100 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (60793-854-01) · 60793-854-01
- 1000 TABLET in 1 BOTTLE (60793-854-10) · 60793-854-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →